Dr Lelia Delamarre | Group Leader, Cancer Immunotherapy Department

Dr Lelia Delamarre, Group Leader, Cancer Immunotherapy Department, Genetech

Lélia Delamarre joined the Cancer Immunotherapy Department at Genentech after completing her postdoctoral training at Yale University where she studied the cell biology of antigen presentation in dendritic cells. She obtained a PhD in Virology from Université Pierre et Marie Curie in France. At Genentech, her laboratory explores novel strategies to elicit protective T cell responses against cancer

back to speakers